Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Idrevloride

Generic Name: Idrevloride

Drug Type: Small Molecule

Chemical Formula: C_₃₀H_₄₉ClN_₈O_₇

CAS Number: 1416973-63-1

Unique Ingredient Identifier: NY2J56S3YA

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Clearing Lungs With ENaC Inhibition in Primary Ciliary Dyskinesia

Phase 2

Completed

Posted: 2016/08/18

Sponsor:

Parion Sciences

ID:NCT02871778

A Study to Evaluate the Safety and Efficacy of VX-371 in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation

Phase 2

Completed

Posted: 2016/03/15

Sponsor:

Parion Sciences

ID:NCT02709109

Clearing Lungs With Epithelial Sodium Channel (ENaC) Inhibition in Cystic Fibrosis (CF)

Phase 2

Completed

Posted: 2015/01/22

Sponsor:

Parion Sciences

ID:NCT02343445

Phase 1b Safety, Tolerability, and PK Study to Assess GS-5737 in Subjects With CF

Phase 1

Completed

Posted: 2013/04/26

Sponsor:Gilead Sciences

ID:NCT01840735

A Phase 1 Study to Characterize the Effect of GS-5737 Enhancement of Mucociliary Clearance (MCC) in Healthy Subjects

Phase 1

Terminated

Posted: 2013/02/15

Sponsor:Gilead Sciences

ID:NCT01793649

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy